Articles by Cliff Goodman, PhD

Data about escalating prices for cancer drugs laid the groundwork for the panel that followed, where Michael E. Chernew, PhD, Harvard health economist and co-editor-in-chief of The American Journal of Managed Care, outlined how changing the paradigm will require a different kind of shopping.

Cancer Patients Need Better Information, and Payers Should Demand They Receive It
ByCliff Goodman, PhD,A. Mark Fendrick, MD,John L. Fox, MD, MHA,Ira M. Klein, MD, MBA, FACP Cliff Goodman, PhD, moderated a panel discussion on the Implications of Healthcare Reform: 'No' Will Be Heard.

Care Reflects Patient Choice, but Having the Data Reflect 'Consumerism' Is Another Matter
ByCliff Goodman, PhD,Amy Berman, BS, RN,Dennis Scanlon, PhD,Manasi A. Tirodkar, PhD, MS, Cliff Goodman, PhD, senior vice president and principal, The Lewis Group, moderated the panel discussion, The Role of Consumerism in the Deliverability of Care.�

How can pharmaceutical companies adapt to a changing environment? Are they the source of the problem, or have they simply responded to US Food and Drug Administration mandates?

The final panel of the conference analyzes the role of the industry in healthcare, including panelists' observations on topics such as innovation. Mr Gamble, for instance, offers his insights as to how groups like the Community Oncology Alliance are working with the industry to drive the message about the quality and the value component throughout all the stakeholders. Dr Fox provides perspective on how payers can offer valuable partnerships throughout the industry, including those with pharmaceutical companies.

Dr Cliff Goodman leads a discussion featuring panelists including The American Journal of Managed Care's co-editor-in-chief, Dr Michael Chernew. Topics of the discussion include the impact of value-based pricing in the market, and how different pricing models such as bundled payments or accountable care organizations impact risk factors.

Discussion 2: Implications of Healthcare Reform: 'No†Will Be Heard
ByCliff Goodman, PhD,A. Mark Fendrick, MD,John L. Fox, MD, MHA,Ira M. Klein, MD, MBA, FACP Implications of Healthcare Reform: 'No' Will Be Heard is led by Cliff Goodman, PhD, in a panel discussion featuring A. Mark Fendrick, MD, co-editor in chief of The American Journal of Managed Care, John L. Fox, MD, MHA, and Ira M. Klein, MD, MBA, FACP. The panelists determine what it means when a patient says no.

Discussion 1: The Role of Consumerism in Deliverability of Care
ByCliff Goodman, PhD,Amy Berman, BS, RN,Dennis Scanlon, PhD,Manasi A. Tirodkar, PhD, MS, Cliff Goodman, PhD, senior vice president and principal at the Lewin Group, kicks off the first discussion of AJMC's PCOC 2013 by introducing panelists Amy Berman, BS, RN, Dennis Scanlon, PhD, and Manasi A. Tirodkar, PhD, MS, as they consider the role of consumerism in deliverability of care.